These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 29089191)
1. A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging. Stockwell MS; Marchant CD; Wodi AP; Barnett ED; Broder KR; Jakob K; Lewis P; Kattan M; Rezendes AM; Barrett A; Sharma D; Fernandez N; LaRussa P Vaccine; 2017 Dec; 35(50):6941-6948. PubMed ID: 29089191 [TBL] [Abstract][Full Text] [Related]
2. Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza Vaccination. Stockwell MS; Broder KR; Lewis P; Jakob K; Iqbal S; Fernandez N; Sharma D; Barrett A; LaRussa P J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e7-e14. PubMed ID: 27302328 [TBL] [Abstract][Full Text] [Related]
3. Risk of fever after pediatric trivalent inactivated influenza vaccine and 13-valent pneumococcal conjugate vaccine. Stockwell MS; Broder K; LaRussa P; Lewis P; Fernandez N; Sharma D; Barrett A; Sosa J; Vellozzi C JAMA Pediatr; 2014 Mar; 168(3):211-9. PubMed ID: 24395025 [TBL] [Abstract][Full Text] [Related]
5. Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial. Stockwell MS; Kharbanda EO; Martinez RA; Vargas CY; Vawdrey DK; Camargo S JAMA; 2012 Apr; 307(16):1702-8. PubMed ID: 22535855 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of Text Message Influenza Vaccine Safety Monitoring During Pregnancy. Stockwell MS; Cano M; Jakob K; Broder KR; Gyamfi-Bannerman C; Castaño PM; Lewis P; Barrett A; Museru OI; Castellanos O; LaRussa PS Am J Prev Med; 2017 Sep; 53(3):282-289. PubMed ID: 28495223 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study. Airey J; Albano FR; Sawlwin DC; Jones AG; Formica N; Matassa V; Leong J Vaccine; 2017 May; 35(20):2745-2752. PubMed ID: 28390934 [TBL] [Abstract][Full Text] [Related]
8. Impacting delayed pediatric influenza vaccination: a randomized controlled trial of text message reminders. Hofstetter AM; Vargas CY; Camargo S; Holleran S; Vawdrey DK; Kharbanda EO; Stockwell MS Am J Prev Med; 2015 Apr; 48(4):392-401. PubMed ID: 25812465 [TBL] [Abstract][Full Text] [Related]
11. Comparison of text-messaging to voice telephone interviews for active surveillance of adverse events following immunisation. Regan AK; Blyth CC; Tracey L; Mak DB; Richmond PC; Effler PV Vaccine; 2015 Jul; 33(31):3689-94. PubMed ID: 26079616 [TBL] [Abstract][Full Text] [Related]
12. Text message reminders for second dose of influenza vaccine: a randomized controlled trial. Stockwell MS; Hofstetter AM; DuRivage N; Barrett A; Fernandez N; Vargas CY; Camargo S Pediatrics; 2015 Jan; 135(1):e83-91. PubMed ID: 25548329 [TBL] [Abstract][Full Text] [Related]
13. Live attenuated influenza vaccine use and safety in children and adults with asthma. Duffy J; Lewis M; Harrington T; Baxter R; Belongia EA; Jackson LA; Jacobsen SJ; Lee GM; Naleway AL; Nordin J; Daley MF; Ann Allergy Asthma Immunol; 2017 Apr; 118(4):439-444. PubMed ID: 28390584 [TBL] [Abstract][Full Text] [Related]
14. Safety of Live Attenuated Influenza Vaccine in Children With Asthma. Sokolow AG; Stallings AP; Kercsmar C; Harrington T; Jimenez-Truque N; Zhu Y; Sokolow K; Moody MA; Schlaudecker EP; Walter EB; Staat MA; Broder KR; Creech CB Pediatrics; 2022 Apr; 149(4):. PubMed ID: 35342923 [TBL] [Abstract][Full Text] [Related]
15. Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014. Haber P; Moro PL; Cano M; Lewis P; Stewart B; Shimabukuro TT Vaccine; 2015 Apr; 33(16):1987-92. PubMed ID: 25678241 [TBL] [Abstract][Full Text] [Related]
16. Text messages for influenza vaccination among pregnant women: A randomized controlled trial. Yudin MH; Mistry N; De Souza LR; Besel K; Patel V; Blanco Mejia S; Bernick R; Ryan V; Urquia M; Beigi RH; Moniz MH; Sgro M Vaccine; 2017 Feb; 35(5):842-848. PubMed ID: 28062124 [TBL] [Abstract][Full Text] [Related]
17. Text Message Reminders for Child Influenza Vaccination in the Setting of School-Located Influenza Vaccination: A Randomized Clinical Trial. Szilagyi PG; Schaffer S; Rand CM; Goldstein NPN; Younge M; Mendoza M; Albertin CS; Concannon C; Graupman E; Hightower AD; Yoo BK; Humiston SG Clin Pediatr (Phila); 2019 Apr; 58(4):428-436. PubMed ID: 30600690 [TBL] [Abstract][Full Text] [Related]
18. Text message reminders for vaccination of adolescents with chronic medical conditions: A randomized clinical trial. Hofstetter AM; Barrett A; Camargo S; Rosenthal SL; Stockwell MS Vaccine; 2017 Aug; 35(35 Pt B):4554-4560. PubMed ID: 28736201 [TBL] [Abstract][Full Text] [Related]
19. Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial. Cadorna-Carlos JB; Nolan T; Borja-Tabora CF; Santos J; Montalban MC; de Looze FJ; Eizenberg P; Hall S; Dupuy M; Hutagalung Y; Pépin S; Saville M Vaccine; 2015 May; 33(21):2485-92. PubMed ID: 25843270 [TBL] [Abstract][Full Text] [Related]
20. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh. Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]